Deep mutational scanning reveals EGFR mutations conferring resistance to the 4th-generation EGFR tyrosine kinase inhibitor BLU-945

Yueyang Wang, John T. Poirier(Memorial Sloan Kettering Cancer Center)
npj Precision Oncology
August 20, 2025
Cited by 3


Related Papers